NewGenIvf Group Limited (NIVF)
NewGenIvf Group Limited at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
NewGenIvf Group Limited (NIVF) is a Medical - Care Facilities company based in TH with a market capitalization of $523.9K. Revenue declined 13.0% year-over-year and free cash flow was negative at -$16.7M. This page tracks NIVF's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
TH · 76 employees · IPO Mar 18, 2022
Valuation
Valuation & price
$0.90 · as of May 17, 2026 · -99.7% vs 52w high
0.1
P/E ratio
Latest-FY diluted EPS
0.02
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$523.9K
Market cap
-13.0%
Revenue growth (YoY)
20.2%
Gross margin
-$16.7M
Free cash flow (USD)
$4.1M
Net debt
0.0%
Share dilution
3/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2021 → 2025
Free cash flow by year
2021 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
2
Insider buys · 90 days
2
Insider sells · 90 days
Earnings
Last reported: Jun 30, 2026 (EPS $-2.02)
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- 6-K filingReverse Stock SplitJul 1, 2026Filing
- 6-K filingStrategic Acquisition AnnouncementJun 22, 2026Filing
- 6-K filingShare Purchase AgreementJun 18, 2026Filing
- 6-K filingRepurchase AgreementJun 16, 2026Filing
- 6-K filingManagement ChangeJun 11, 2026Filing
- Insider sellInsider Sell $51KHRT FINANCIAL LP · 10% Owner · $50.7KJun 8, 2026Filing
- 6-K filingShare Purchase AgreementJun 4, 2026Filing
- Insider buyInsider Buy $32KHRT FINANCIAL LP · 10% Owner · $32KJun 4, 2026Filing
- 6-K filingShare Purchase AgreementMay 28, 2026Filing
- Insider sellInsider Sell $68KHRT FINANCIAL LP · 10% Owner · $68.3KMay 28, 2026Filing
Questions
Frequently asked questions
What is NewGenIvf Group Limited's market cap?
NewGenIvf Group Limited (NIVF) has a market capitalization of $523.9K.
What is NIVF's P/E ratio?
NIVF trades at a price-to-earnings ratio of 0.1, based on its latest fiscal-year diluted earnings per share and the most recent cached price.
What is NIVF's price-to-book (P/B) ratio?
NIVF trades at 0.02 times book value per share.
When did NewGenIvf Group Limited last report earnings?
NIVF last reported earnings on June 30, 2026; the next date is not yet scheduled.
Are insiders buying NIVF stock?
Yes — SEC Form 4 filings show 2 open-market insider buys and 2 sells at NewGenIvf Group Limited in the last 90 days.
Same arena
Related companies in Medical - Care Facilities
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.